These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12100475)

  • 41. Quantitation of serum amyloid P component by an enzyme-linked immunoassay.
    Serban D; Rordorf-Adam C
    J Immunol Methods; 1986 Jun; 90(2):159-64. PubMed ID: 3722822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigating interactions of the pentraxins serum amyloid P component and C-reactive protein by mass spectrometry.
    Aquilina JA; Robinson CV
    Biochem J; 2003 Oct; 375(Pt 2):323-8. PubMed ID: 12892563
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc gamma Rs.
    Mold C; Gresham HD; Du Clos TW
    J Immunol; 2001 Jan; 166(2):1200-5. PubMed ID: 11145702
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CRP and SAP from different species have different membrane ligand specificities.
    Mattecka S; Bock C; Vogt B; Yapici G; Schrödl W; Janko C; Schindler R; Sheriff A
    Autoimmunity; 2013 Aug; 46(5):347-50. PubMed ID: 23600950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
    de Haas CJ; van der Tol ME; Van Kessel KP; Verhoef J; Van Strijp JA
    J Immunol; 1998 Oct; 161(7):3607-15. PubMed ID: 9759883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Receptor-ligand interactions between serum amyloid P component and model soluble immune complexes.
    Brown MR; Anderson BE
    J Immunol; 1993 Aug; 151(4):2087-95. PubMed ID: 8393897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant human serum amyloid P component from Pichia pastoris: production and characterization.
    Boysen S; Fogh-Schultz B; Andersen I; Højrup P; Iversen JJ; Wittenhagen P; Nielsen EH; Svehag SE
    Protein Expr Purif; 2004 Jun; 35(2):284-92. PubMed ID: 15135404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binding of serum amyloid P-component (SAP) by amyloid fibrils.
    Pepys MB; Dyck RF; de Beer FC; Skinner M; Cohen AS
    Clin Exp Immunol; 1979 Nov; 38(2):284-93. PubMed ID: 118839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro.
    Ozawa D; Nomura R; Mangione PP; Hasegawa K; Okoshi T; Porcari R; Bellotti V; Naiki H
    Sci Rep; 2016 Jul; 6():29077. PubMed ID: 27380955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative Western blot assay for measurement of the murine acute phase reactant, serum amyloid P component.
    Griswold DE; Hillegass L; Antell L; Shatzman A; Hanna N
    J Immunol Methods; 1986 Jul; 91(2):163-8. PubMed ID: 3525679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A study of a covalent-like interaction between soluble nascent C4b and C4-binding protein.
    Villiers MB; Thielens NM; Reboul A; Colomb MG
    Biochim Biophys Acta; 1982 Jun; 704(2):197-203. PubMed ID: 6980671
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q.
    Ying SC; Gewurz AT; Jiang H; Gewurz H
    J Immunol; 1993 Jan; 150(1):169-76. PubMed ID: 8417122
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding of human serum amyloid P-component to phosphocholine.
    Christner RB; Mortensen RF
    Arch Biochem Biophys; 1994 Nov; 314(2):337-43. PubMed ID: 7979374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolation and characterization of rat plasma fibronectin.
    Weiss RE; Reddi AH
    Biochem J; 1981 Sep; 197(3):529-34. PubMed ID: 7034721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies of the in vivo synthesis and catabolism of serum amyloid P component (SAP) in the mouse.
    Baltz ML; Dyck RF; Pepys MB
    Clin Exp Immunol; 1985 Jan; 59(1):235-42. PubMed ID: 3882285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification and isolation of two pentraxins from bovine serum.
    Maudsley S; Rowe IF; de Beer FC; Munn EA; Herbert J; Feinstein A; Pepys MB
    Clin Exp Immunol; 1987 Mar; 67(3):662-73. PubMed ID: 3608235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new pentraxin (serum amyloid P-component) in the rat: evidence for two quaternary structures and effect of ligands on self-association.
    Pontet M; D'Asnieres M; Gache D; Escaig J; Engler R
    Biochim Biophys Acta; 1981 Dec; 671(2):202-10. PubMed ID: 7326264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen.
    Noursadeghi M; Bickerstaff MC; Gallimore JR; Herbert J; Cohen J; Pepys MB
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14584-9. PubMed ID: 11121061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunohistochemical studies of amyloid P component and fibronectin in erythropoietic protoporphyria.
    Breathnach SM; Bhogal B; de Beer FC; Melrose SM; Black MM; Pepys MB
    Br J Dermatol; 1983 Mar; 108(3):267-75. PubMed ID: 6338898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neutralization of the anticoagulant effects of glycosaminoglycans by serum amyloid P component: comparison with other plasma and platelet proteins.
    Williams EC; Huppert BJ; Asakura S
    J Lab Clin Med; 1992 Jul; 120(1):159-67. PubMed ID: 1377216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.